Download Files:
Octreotide (acetate)
$38 – $115
Products Details
Product Description
– Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently.
Web ID
– HY-17365
Storage Temperature
– -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Shipping
– Blue Ice
Applications
– COVID-19-immunoregulation
Molecular Formula
– C51H70N10O12S2
Citations
– Nat Commun. 2023 Feb 21;14(1):962.|Research Square Print. 2022 Aug.|Basic Clin Pharmacol Toxicol. 2022 Jun 10.|Cell Mol Bioeng. 2022.|Faculty of Biological and Environmental Sciences. University of Helsinki Finland. 2018 Dec.|J Pharm Biomed Anal. 11 December 2021, 114518.|J Pharm Biomed Anal. 2022: 115156.|J Pharm Sci. 2022 Oct 10;S0022-3549(22)00454-3.
References
– [1]Kim S, et al. Treatment of Gastrin-Secreting Tumor With Sustained-Release Octreotide Acetate in a Dog. J Am Anim Hosp Assoc. 2015 Nov-Dec;51(6):407-12.|[2]Wang M, et al. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide. J Control Release. 2016 May 28;230:45-56.
CAS Number
– 79517-01-4
Molecular Weight
– 1079.29
Compound Purity
– 99.93
SMILES
– O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@H](CO)[C@H](O)C)=O)NC([C@H](N)CC2=CC=CC=C2)=O)=O)CC3=CC=CC=C3)N[C@@H]1CC4=CNC5=CC=CC=C45.CC(O)=O
Clinical Information
– Launched
Research Area
– Inflammation/Immunology; Cardiovascular Disease; Endocrinology; Cancer
Solubility
– DMSO : 250 mg/mL (ultrasonic)|H2O : 25 mg/mL (ultrasonic)
Target
– Somatostatin Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Peptides
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
